(Q84943384)

English

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)

scientific article published on 13 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

peritoneal carcinoma

1 reference

based on heuristic

inferred from title

neoadjuvant chemotherapy

1 reference

based on heuristic

inferred from title

1

object named as

Dennis S Chi

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Richard R Barakat

10

object named as

Richard R Barakat

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

5

object named as

Yukio Sonoda

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Nadeem R. Abu-Rustum

9

object named as

Nadeem R Abu-Rustum

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ginger J. Gardner

8

object named as

Ginger J Gardner

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Oliver Zivanovic

4

object named as

Oliver Zivanovic

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Douglas A Levine

7

object named as

Douglas A Levine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

3

object named as

Fanny Dao

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Fernanda Musa

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Mario M Leitao

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

13 September 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

124

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

10-14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Quality of complication reporting in the surgical literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Feasibility and safety of extensive upper abdominal surgery in elderly patients with advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.08.014

7 January 2021

Identifiers

10.1016/J.YGYNO.2011.08.014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21917306%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84943384&oldid=1933782780"